Cargando…
Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
BACKGROUND: In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The firs...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476169/ https://www.ncbi.nlm.nih.gov/pubmed/26082155 http://dx.doi.org/10.1186/s13071-015-0942-y |
_version_ | 1782377562566033408 |
---|---|
author | Girish, Sonal Kumar, Suresh Aminudin, Norhaniza |
author_facet | Girish, Sonal Kumar, Suresh Aminudin, Norhaniza |
author_sort | Girish, Sonal |
collection | PubMed |
description | BACKGROUND: In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The first part of this study aims to screen for the anti-protozoal activity of these herbal plant extracts against Blastocystis sp. isolate subtype (ST) 3. Herbal extract with the highest efficacy was further fractionized into water and ethyl acetate fractions and tested against ST1, ST3 and ST5 Blastocystis sp. isolates. These isolates were also exposed to allopathic drugs, Metronidazole (MTZ), Tinidazole, Trimethoprim-sulfamethoxazole(TMP-SMX), Ketoconazole and Nitazoxanide for comparison purpose. METHODS: Blastocystis sp. isolates from human-derived stool samples were exposed to herbal extracts and allopathic drugs at a concentration of 0.1 mg/ml and 1.0 mg/ml and were incubated at 37 °C. Growth profile studies were carried out. After 72 h of treatment, the viability of Blastocystis sp. as a result of the effects of the drugs and herbal extracts were assessed. RESULTS: Based on the screening process, amongst all the extracts, Tongkat Ali exhibited the highest anti-protozoal activity at 1.0 mg/ml. Between the water and ethyl acetate fractions of Tongkat Ali, the ethyl acetate fraction exhibited a slightly higher percentage of anti-protozoal activity at 1.0 mg/ml across subtypes, ST1 (94.9 %), ST3 (95.1 %) and ST5 (94.3 %). When tested with allopathic drugs, at the same concentration, MTZ exhibited the highest anti-protozoal activity across subtypes, ST1 (95.8 %), ST3 (93.4 %) and ST5 (90.8 %). CONCLUSION: This study is the first to describe the anti-protozoal properties of Tongkat Ali against Blastocystis sp. isolates. Ethyl acetate fraction of Tongkat Ali demonstrated the highest anti-protozoal activity against Blastocystis sp. isolates and showed a sizeable reduction in the cell count which was comparable with MTZ. Tongkat Ali also demonstrated a more uniformed sensitivity across subtypes in comparison to the allopathic drugs. |
format | Online Article Text |
id | pubmed-4476169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44761692015-06-23 Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. Girish, Sonal Kumar, Suresh Aminudin, Norhaniza Parasit Vectors Research BACKGROUND: In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The first part of this study aims to screen for the anti-protozoal activity of these herbal plant extracts against Blastocystis sp. isolate subtype (ST) 3. Herbal extract with the highest efficacy was further fractionized into water and ethyl acetate fractions and tested against ST1, ST3 and ST5 Blastocystis sp. isolates. These isolates were also exposed to allopathic drugs, Metronidazole (MTZ), Tinidazole, Trimethoprim-sulfamethoxazole(TMP-SMX), Ketoconazole and Nitazoxanide for comparison purpose. METHODS: Blastocystis sp. isolates from human-derived stool samples were exposed to herbal extracts and allopathic drugs at a concentration of 0.1 mg/ml and 1.0 mg/ml and were incubated at 37 °C. Growth profile studies were carried out. After 72 h of treatment, the viability of Blastocystis sp. as a result of the effects of the drugs and herbal extracts were assessed. RESULTS: Based on the screening process, amongst all the extracts, Tongkat Ali exhibited the highest anti-protozoal activity at 1.0 mg/ml. Between the water and ethyl acetate fractions of Tongkat Ali, the ethyl acetate fraction exhibited a slightly higher percentage of anti-protozoal activity at 1.0 mg/ml across subtypes, ST1 (94.9 %), ST3 (95.1 %) and ST5 (94.3 %). When tested with allopathic drugs, at the same concentration, MTZ exhibited the highest anti-protozoal activity across subtypes, ST1 (95.8 %), ST3 (93.4 %) and ST5 (90.8 %). CONCLUSION: This study is the first to describe the anti-protozoal properties of Tongkat Ali against Blastocystis sp. isolates. Ethyl acetate fraction of Tongkat Ali demonstrated the highest anti-protozoal activity against Blastocystis sp. isolates and showed a sizeable reduction in the cell count which was comparable with MTZ. Tongkat Ali also demonstrated a more uniformed sensitivity across subtypes in comparison to the allopathic drugs. BioMed Central 2015-06-18 /pmc/articles/PMC4476169/ /pubmed/26082155 http://dx.doi.org/10.1186/s13071-015-0942-y Text en © Girish et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Girish, Sonal Kumar, Suresh Aminudin, Norhaniza Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. |
title | Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. |
title_full | Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. |
title_fullStr | Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. |
title_full_unstemmed | Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. |
title_short | Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. |
title_sort | tongkat ali (eurycoma longifolia): a possible therapeutic candidate against blastocystis sp. |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476169/ https://www.ncbi.nlm.nih.gov/pubmed/26082155 http://dx.doi.org/10.1186/s13071-015-0942-y |
work_keys_str_mv | AT girishsonal tongkatalieurycomalongifoliaapossibletherapeuticcandidateagainstblastocystissp AT kumarsuresh tongkatalieurycomalongifoliaapossibletherapeuticcandidateagainstblastocystissp AT aminudinnorhaniza tongkatalieurycomalongifoliaapossibletherapeuticcandidateagainstblastocystissp |